Endo Reaches $10M Deal With SF Ahead Of Opioid Trial

By Hailey Konnath (April 20, 2022, 11:01 PM EDT) -- Endo Pharmaceuticals has agreed to pay $10 million over the course of 10 years to resolve the city of San Francisco's claims stemming from the drugmaker's role in the opioid crisis, a deal that comes just days before the company's bellwether bench trial was set to kick off in California federal court, according to an announcement Wednesday.  ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!